Krystal AD

Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco.

3 papers

ArticlePsilocybin

An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.

Downey AE, Szigeti B, Bradley ER +11

Europe PMC2026
ArticlePsilocybin

Treatment Expectancies and Psilocybin vs Escitalopram for Depression.

Dutcher EG, Krystal AD

Europe PMC2025
ArticlePsilocybin

A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?

Downey AE, Bradley ER, Lerche AS +3

Europe PMC2024